![]()
BRS-X-Hormones-1-4 - Metabolic-Reproductive Hormone Integration
1. Mission & Overview
Mission
Enable coordinated integration of insulin and metabolic signalling with reproductive hormone balance.
Intervention Dominance: Diet-Supported — System Optimisation Practices
The established influence is bounded to the measured endpoint and exposure context.
- Low-GI dietary pattern in PCOS
Overview
Metabolic signals can influence reproductive hormone production, rather than merely accompanying it. Insulin experiments in ovarian cells identify one direct connection. In women with PCOS, a low-glycaemic-index dietary pattern improved selected insulin-sensitivity and menstrual-cycle readouts compared with a healthy comparison diet. This supports a contextual dietary-practice route, not a requirement for one isolated food or nutrient. The endocrine response depends on the population and treatment context; improved cyclicity does not establish a uniform change in every reproductive hormone. Nestler et al. (1998) [3]; Marsh et al. (2010) [4]
- Biological Relevance: Insulin stimulated testosterone production through its receptor and an inositolglycan-sensitive signalling route. Nestler et al. (1998) [3]
- Implementation Notes: Use the bounded dietary-pattern relationship below; its context and limitations travel with the disclosure.
2. Primary Biological Effects
- Insulin stimulated testosterone production through its receptor and an inositolglycan-sensitive signalling route. Nestler et al. (1998) [3]
- Completers showed better oral-test insulin sensitivity and menstrual cyclicity with low GI; reproductive hormone superiority was not established. Marsh et al. (2010) [4]
3. Levers
No Direct or Derived Dietary Requirement is currently established.
No evidence-supported cofactors or substrates are currently established for this mechanism.
No mapping established.
No evidence-qualified Lifestyle Lever is currently established.
4. Mechanistic Basis
Summary
Insulin stimulated testosterone production through its receptor and an inositolglycan-sensitive signalling route. Nestler et al. (1998) [3]
Mechanism boundary: The dietary trial did not establish insulin mediation or superior reproductive hormone concentrations; broader reproductive and neural benefit is unestablished.
4.1 Scientific Findings (2)
Scientific Findings and their source assessments are available in Evidence & Audit.
5. BRS Pathways and Connections
5.1 BRS Pathways
- None listed
5.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS-X(Hormones-FM1) — Reproductive Hormone Balance & Neurocognitive Regulation — Parent integration combines these child processes without establishing a new nutrient or outcome claim.
- BRS-X(Hormones-PM1) — Oestrogen Signalling Stability — Assesses neural estrogen responses; intestinal recycling and circulating concentration are different endpoints.
- BRS-X(Hormones-PM2) — Estrobolome Regulation — Assesses microbial estrogen deconjugation; systemic recycling requires its own endpoint evidence.
- BRS1(FM1) — Monoaminergic Function — Candidate contextual connection retained for review; an exposure-specific resource or signalling relationship is not yet characterised.
- BRS5-FM2-PM5 — SCFA Production & Signalling — Candidate contextual connection retained for review; an exposure-specific resource or signalling relationship is not yet characterised.
- BRS5(FM1) — Gut Barrier Integrity & Immune Interface — Candidate contextual connection retained for review; an exposure-specific resource or signalling relationship is not yet characterised.
- BRS6(FM1) — Glycaemic–Insulin Stability & Cognitive Energy Availability — Insulin availability provides metabolic context for steroid synthesis; a clinical response requires the population-specific evidence retained here.
5.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS-X(Hormones-PM1) — Oestrogen Signalling Stability — Assesses neural estrogen responses; intestinal recycling and circulating concentration are different endpoints.
- BRS-X(Hormones-PM2) — Estrobolome Regulation — Assesses microbial estrogen deconjugation; systemic recycling requires its own endpoint evidence.
- BRS-X(Hormones-PM3) — Progesterone-Supportive Microbial Metabolism — Assesses microbial progestin production; endocrine stability is a separately unresolved claim.
Phenome assessment boundary: Existing ratings and their original source records are retained pending outcome reassessment. The new mechanism and lever Findings do not validate or raise those ratings.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Rationale: Insulin sensitivity and metabolic stability interact with reproductive hormone regulation; this PM should be framed as metabolic-endocrine integration rather than a direct ADHD treatment claim.
- Biology → Phenome Relationship Strength: Low
- Evidence Confidence: Low
- Rationale: Metabolic volatility may indirectly influence affective regulation through neuroendocrine and reproductive hormone coupling.
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Rationale: Insulin-linked metabolic signalling and gut ecological context may modulate oestrogen-progesterone balance across feeding and stress cycles.
Stage 2A/2B dietary-target assessment — 23 October 2026
REVIEW REQUIRED. Insulin-to-reproductive endocrine coupling; not generic hormone balancing.
A primary PCOS report has internally inconsistent abstract sample counts and a folate-unit problem. Do not admit isolated myo-inositol or infer insulin-mediated receptor changes until original methods clarify the combination and dose. Existing low-GI PCOS SOP remains intact.
New implementation: 0 dietary-input admissions (0 completed Unset candidates), 0 practices, 0 biochemical participants, 0 unscored Findings. Existing accepted inputs, source assessments, mission, KCs, Phenome relationships and scores are retained.
Source-to-claim boundary: Assessment source. Stop after adjudicating the stated material candidate and tracing supported delivery. Keep uncertain specificity, formulation, anatomical or measurement links explicit; no negative evidence is inferred from incomplete retrieval.
8. References
- [1] Li et al. (2023) — Function of Akkermansia Muciniphila in Type 2 Diabetes and Related Diseases
- [2] De Paoli et al. (2021) — Role of Estrogen in Insulin Resistance
- [3] Nestler et al. (1998) — Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system
- [4] Marsh et al. (2010) — Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome
No validated structured conversion route is currently projected for this PM. This does not remove or reclassify its existing dietary inputs.
Mapping state: canonical-record-review-required.